OFM
EDIT icon

Omega Fund Management’s Editas Medicine EDIT Stock Holding History

Omega Fund Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-66,162
Closed -$1.07M – 12
2016
Q4 		$1.07M Hold
66,162
– – 0.87% 9
2016
Q3 		$892K Sell
66,162
-38,846
-37% -$796K 0.68% 10
2016
Q2 		$2.56M Buy
105,008
+1
+0% +$34 1.9% 8
2016
Q1 		$3.63M Buy
+105,007
New +$2.76M 2.52% 8

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Omega Fund Management's EDIT Position: Q1 2017 in Review

Omega Fund Management sold out of Editas Medicine (EDIT) in Q1 2017, closing a stake of 66,162 shares — an estimated $1.07M sold.

Omega Fund Management first reported a position in EDIT in Q1 2016 and held it in 4 quarters. The position peaked at $3.63M in Q1 2016. 99 funds tracked by Wall St. Rank hold EDIT as of Q1 2017.

  • Omega Fund Management reported no remaining Editas Medicine position as of Q1 2017 after selling out during the quarter.
  • Omega Fund Management sold 66,162 Editas Medicine shares in Q1 2017, an estimated $1.07M.
  • Omega Fund Management first reported a position in Editas Medicine in Q1 2016 and held it in 4 quarters.
  • Omega Fund Management's Editas Medicine position peaked at $3.63M in Q1 2016.
  • 99 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2017.

Based on Omega Fund Management's 13F filing for Q1 2017, filed 9 May 2017.